Literature DB >> 17451842

National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care.

Alex G Little1, E Greer Gay, Laurie E Gaspar, Andrew K Stewart.   

Abstract

PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
METHODS: In 2001 the National Cancer Data Base, under direction of the American College of Surgeons, conducted a patient care evaluation study in 719 hospitals. We collected information on patient demographics and histories, diagnostic and staging methods, pathology, and initial treatment.
RESULTS: Information on 40,909 patients was obtained; 93% were smokers. Slightly more than half were older than 70 years; 58.5% were male and 35% had adenocarcinoma. Comorbid conditions were present in 71.8% and 22% had a prior malignancy. A chest CT scan was performed in 92% of patients and PET scans in 19.3%. Mediastinoscopy was performed in 20.3%. 67.2% of patients had Stage III or IV disease. More of the Hispanic, Asian or Black patients than White had Stage IV disease (p<0.01). Treatment was multimodality in a little over 30% of patients. Surgery alone was primarily utilized for patients in Stage I or II. Choice of treatment correlated more with stage and age than comorbidities.
CONCLUSION: Our results substantiated the pattern of increasing proportions of women with NSCLC and the increasing frequency of adenocarcinoma. Most patients presented with Stage III or IV disease. Ethnic minorities were more likely to present in late stage disease than Whites. Treatment strategies depended more on stage and age than comorbid burden. Older patients were less likely to receive surgery and more likely to be treated with radiation only or have no treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17451842     DOI: 10.1016/j.lungcan.2007.03.012

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  67 in total

1.  Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma.

Authors:  Ying-Fu Liu; Yong-Heng Chen; Mao-Yu Li; Peng-Fei Zhang; Fang Peng; Guo-Qing Li; Zhi-Qiang Xiao; Zhu-Chu Chen
Journal:  Med Oncol       Date:  2010-12-04       Impact factor: 3.064

2.  Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.

Authors:  Robert A Meguid; Craig M Hooker; James Harris; Li Xu; William H Westra; J Timothy Sherwood; Marc Sussman; Stephen M Cattaneo; James Shin; Solange Cox; Joani Christensen; Yelena Prints; Nance Yuan; Jennifer Zhang; Stephen C Yang; Malcolm V Brock
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

Review 3.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 4.  [Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing].

Authors:  A Warth; L Bubendorf; S Gütz; A Morresi-Hauf; M Hummel; K Junker; U Lehmann; I Petersen; P A Schnabel
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

5.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

6.  'One-stop shop': lung cancer patients' and caregivers' perceptions of multidisciplinary care in a community healthcare setting.

Authors:  Satish K Kedia; Kenneth D Ward; Siri A Digney; Bianca M Jackson; April L Nellum; Laura McHugh; Kristina S Roark; Orion T Osborne; Fayre J Crossley; Nicholas Faris; Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Authors:  Mustafa S Ascha; Quinn T Ostrom; James Wright; Priya Kumthekar; Jeremy S Bordeaux; Andrew E Sloan; Fredrick R Schumacher; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05       Impact factor: 4.254

8.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

9.  Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.

Authors:  Angela C Tramontano; Lauren E Cipriano; Chung Yin Kong; Jo-Anne O Shepard; Michael Lanuti; G Scott Gazelle; Pamela M McMahon
Journal:  AJR Am J Roentgenol       Date:  2013-05       Impact factor: 3.959

10.  Prognostic significance of annexin II expression in non-small cell lung cancer.

Authors:  C-H Luo; Q-Q Liu; P-F Zhang; M-Y Li; Z-C Chen; Y-F Liu
Journal:  Clin Transl Oncol       Date:  2013-03-26       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.